Noveris Health Sciences is trading at CA$0.09, down -5.26%, with no clear company-specific catalyst identified for September 14, 2026.
- The latest reported announcement was September 9, when shareholders approved all meeting resolutions, including director elections; it does not explain todayβs decline.
- Broader markets were only modestly lower, so the move cannot be confidently attributed to market-wide sentiment.